作者: Amirhossein Bahreyni , Honglin Luo
关键词:
摘要: Short interfering RNAs (siRNAs) have provided novel insights into the field of cancer treatment in light their ability to specifically target and silence cancer-associated genes. In recent years, numerous studies focus on determining genes that actively participate tumor formation, invasion, metastasis order establish new targets for treatment. spite great advances designing various siRNAs with diverse targets, efficient delivery cells is still main challenge siRNA-mediated Recent advancements nanotechnology nanomedicine hold promise meet this challenge. This review focuses findings application successfully them prostate cancer, as well progress effectual cells.